KRUSE BO (EVP, CFO, Secy & Treas.) received a stock award from Y-MABS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/22/2024ACC: 0001415889-24-001644
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
+127K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
127K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+18.10K
Price / share
—
Trade value
—
% of position
9.4%
1/18/2024
192.78K→210.88K
Total
Net shares
+18.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2024 | A · Award | +18.10K | — | — | 9.4% | 192.78K | 210.88K |
| Total | +18.10K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
108.90K shares
Shares
+108.90K
Strike price
9.83
Held after
108.90K
Exercisable
—
1/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock108.90K shares | 1/18/2024 | A · Award | +108.90K | 9.83 | — | 108.90K |